These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7797904)

  • 1. Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein.
    von der Möhlen MA; Kimmings AN; Wedel NI; Mevissen ML; Jansen J; Friedmann N; Lorenz TJ; Nelson BJ; White ML; Bauer R
    J Infect Dis; 1995 Jul; 172(1):144-51. PubMed ID: 7797904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant amino terminal fragment of bactericidal/permeability-increasing protein inhibits the induction of leukocyte responses by LPS.
    Mészáros K; Parent JB; Gazzano-Santoro H; Little R; Horwitz A; Parsons T; Theofan G; Grinna L; Weickmann J; Elsbach P
    J Leukoc Biol; 1993 Dec; 54(6):558-63. PubMed ID: 8245707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endotoxin in acute inflammation induced by gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing protein.
    Kohn FR; Kung AH
    Infect Immun; 1995 Jan; 63(1):333-9. PubMed ID: 7806373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of endotoxin-induced activation of the coagulation and fibrinolytic pathways using a recombinant endotoxin-binding protein (rBPI23).
    von der Möhlen MA; van Deventer SJ; Levi M; van den Ende B; Wedel NI; Nelson BJ; Friedmann N; ten Cate JW
    Blood; 1995 Jun; 85(12):3437-43. PubMed ID: 7780131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
    J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria.
    Gazzano-Santoro H; Mészáros K; Birr C; Carroll SF; Theofan G; Horwitz AH; Lim E; Aberle S; Kasler H; Parent JB
    Infect Immun; 1994 Apr; 62(4):1185-91. PubMed ID: 8132325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of a recombinant fragment of bactericidal/permeability increasing protein against carbohydrate dyshomeostasis and tumor necrosis factor-alpha elevation in rat endotoxemia.
    Lin Y; Kohn FR; Kung AH; Ammons WS
    Biochem Pharmacol; 1994 Apr; 47(9):1553-9. PubMed ID: 8185667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans.
    Pajkrt D; Manten A; van der Poll T; Tiel-van Buul MM; Jansen J; Wouter ten Cate J; van Deventer SJ
    Blood; 1997 Aug; 90(4):1415-24. PubMed ID: 9269759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant endotoxin-binding protein (rBPI23) attenuates endotoxin-induced circulatory changes in humans.
    de Winter RJ; von der Möhlen MA; van Lieshout H; Wedel N; Nelson B; Friedmann N; Delemarre BJ; van Deventer SJ
    J Inflamm; 1995; 45(3):193-206. PubMed ID: 8597874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein (rBPI23) on cerebrospinal fluid inflammation induced by endotoxin.
    Kartalija M; Kim Y; White ML; Nau R; Tureen JH; Täuber MG
    J Infect Dis; 1995 Apr; 171(4):948-53. PubMed ID: 7706823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of postponed treatment with an anti-tumour necrosis factor (TNF) F(ab')2 fragment on endotoxin-induced cytokine and neutrophil responses in chimpanzees.
    van der Poll T; Levi M; ten Cate H; Jansen J; Biemond BJ; Haagmans BL; Eerenberg A; van Deventer SJ; Hack CE; ten Cate JW
    Clin Exp Immunol; 1995 Apr; 100(1):21-5. PubMed ID: 7697917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of a recombinant N-terminal fragment of bactericidal/permeability increasing protein on endotoxic shock in conscious rabbits.
    Lin Y; Ammons WS; Leach WJ; Kung AH
    Shock; 1994 Nov; 2(5):324-31. PubMed ID: 7743357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The recombinant 23-kDa N-terminal fragment of bactericidal/permeability-increasing protein (rBPI23) decreases Escherichia coli-induced mortality and organ injury during immunosuppression-related neutropenia.
    Lechner AJ; Lamprech KE; Johanns CA; Matuschak GM
    Shock; 1995 Oct; 4(4):298-306. PubMed ID: 8564560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ blood flow after partial hepatectomy in rats: modification by endotoxin-neutralizing bactericidal/permeability-increasing protein (rBPI23).
    Boermeester MA; Houdijk AP; Straatsburg IH; van Noorden CJ; van Leeuwen PA
    J Hepatol; 1999 Nov; 31(5):905-12. PubMed ID: 10580589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant bactericidal, permeability-increasing protein on bacterial translocation and pulmonary neutrophil sequestration in burned mice.
    Rennekampff OH; Tenenhaus M; Hansbrough J; Kiessig V; Zapata-Sirvent RL
    J Burn Care Rehabil; 1997; 18(1 Pt 1):17-21. PubMed ID: 9063782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal/permeability-increasing protein release in whole blood ex vivo: strong induction by lipopolysaccharide and tumor necrosis factor-alpha.
    Dentener MA; Francot GJ; Hiemstra PS; Tool AT; Verhoeven AJ; Vandenabeele P; Buurman WA
    J Infect Dis; 1997 Jan; 175(1):108-17. PubMed ID: 8985203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant amino-terminal fragment of bactericidal/permeability increasing protein (rBPI23) inhibits soluble CD14-mediated lipopolysaccharide-induced endothelial adherence for human neutrophils.
    Huang K; Conlon PJ; Fishwild DM
    Shock; 1994 Feb; 1(2):81-6. PubMed ID: 7538431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
    J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo interaction of endotoxin and recombinant bactericidal/permeability-increasing protein (rBPI23): hemodynamic effects in a human endotoxemia model.
    Jellema WT; Veerman DP; De Winter RJ; Wesseling KH; Van Deventer SJ; Hack CE; van Lieshout JJ
    J Lab Clin Med; 2002 Oct; 140(4):228-35. PubMed ID: 12389020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.